Search Results 1041-1050 of 19158 for creatinine

1. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   Serum creatinine >1.5 × institutional ULN; Known to be suffering from infection with human immunodeficiency virus (HIV), tuberculosis, Hepatitis C or ...

2. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

   Chronic renal insufficiency defined by a creatinine clearance of < or = to 20 ml/min; Known current use of illegal drugs; Other uncontrolled disease (co ...

3. A Study to Evaluate Stereotactic Radiosurgery Versus Hippocampal-Avoidant Whole Brain Radiotherapy for 10 or Fewer Brain Metastases from Small Cell Lung Cancer - Mayo Clinic

   Creatinine clearance ≥ 30 ml/min;; Following the diagnosis of brain metastases, patients can initiate and treat with systemic (chemotherapy and/or ...

4. Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer - Mayo Clinic

   creatinine ≤ institutional ULN OR creatinine clearance ≥ 60 mL/min/1.73 m^2 for patients with creatinine levels above institutional normal. Baseline left ...

5. Giant Cell Arteritis Vessel Wall Enhancement - Mayo Clinic

   Participants who are receiving a clinically-indicated MRI at the time of enrollment may participate even if they meet exclusion criteria of creatinine clearance ...

6. Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer - Mayo Clinic

   Creatinine clearance ≥ 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional normal; Platelets ≥ 50,000 cells/mm^3; Negative serum ...

7. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids - Mayo Clinic

   Severe renal dysfunction defined as creatinine of 1.5 x ULN. Severe liver dysfunction in the absence of liver metastasis defined by aspartate ...

8. Pembrolizumab And Ibrutinib In Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

   Creatinine £1.5 X ULN and CrCL ≥30 ml/min per Cockcroft Gault formula. *Criteria must be met without a transfusion ≤four weeks prior to registration ...

9. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

   Adequate renal function as evidenced by creatinine clearance ≥ 30 mL/min. Adequate coagulation studies (obtained ≤ 14 days prior to randomisation) as ...

10. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    Estimated (Cockcroft-Gault) or measured creatinine clearance ≥ 30 mL/min. Coagulation: International normalized ratio or prothrombin time (PT) ≤ 1.5 × ULN ...